Development and Applications of CRISPR/Cas9-Based Genome Editing in Lactobacillus

Int J Mol Sci. 2022 Oct 25;23(21):12852. doi: 10.3390/ijms232112852.

Abstract

Lactobacillus, a genus of lactic acid bacteria, plays a crucial function in food production preservation, and probiotics. It is particularly important to develop new Lactobacillus strains with superior performance by gene editing. Currently, the identification of its functional genes and the mining of excellent functional genes mainly rely on the traditional gene homologous recombination technology. CRISPR/Cas9-based genome editing is a rapidly developing technology in recent years. It has been widely applied in mammalian cells, plants, yeast, and other eukaryotes, but less in prokaryotes, especially Lactobacillus. Compared with the traditional strain improvement methods, CRISPR/Cas9-based genome editing can greatly improve the accuracy of Lactobacillus target sites and achieve traceless genome modification. The strains obtained by this technology may even be more efficient than the traditional random mutation methods. This review examines the application and current issues of CRISPR/Cas9-based genome editing in Lactobacillus, as well as the development trend of CRISPR/Cas9-based genome editing in Lactobacillus. In addition, the fundamental mechanisms of CRISPR/Cas9-based genome editing are also presented and summarized.

Keywords: CRISPR/Cas9; Cas9 protein; Lactobacillus; genome editing.

Publication types

  • Review

MeSH terms

  • Animals
  • CRISPR-Cas Systems* / genetics
  • Gene Editing* / methods
  • Lactobacillus / genetics
  • Mammals / genetics

Grants and funding

This research was funded by the Korea Environment Industry & Technology Institute (KEITI) through a project to develop new, eco-friendly materials and processing technology derived from wildlife, funded by the Korea Ministry of Environment (MOE), grant number 2021003240004, as well as by the National Research Foundation of Korea (NRF), with a grant funded by the Korean government, grant number NRF-2018R1C1B3009513. The APC was funded by 2021003240004.